Association of influenza virus infection and inflammatory cytokines with acute myocardial infarction

Inflammation Research

Volumn 61, Issue 6, 2012, Pages 591-598

  Guan, Xiuru ^a   Yang, Wei ^a   Sun, Xijuan ^a   Wang, Lanfeng ^a   Ma, Benjiang ^b   Li, Hongyuan ^c   Zhou, Jin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Acute myocardial infarction; Atherosclerosis; Infection; Inflammatory cytokine; Influenza virus

Indexed keywords

CHOLESTEROL; ENDOTHELIN 1; GAMMA INTERFERON; GLUCOSE; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 6; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOPATHOGENESIS; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; RUBELLA VIRUS; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANTIBODIES, VIRAL; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHOLESTEROL; CYTOKINES; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TRIGLYCERIDES;

EID: 84865109935     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-012-0449-3     Document Type: Article

References (36)

1. Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation. 2000;102:3039-45.
2. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340(2):115-26.
3. Saikku P. Seroepidemiology in Chlamydia pneumoniae-atherosclerosis association. Eur Heart J. 2002;23(4):263-4.
4. Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, et al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol. 2005;45:1219-22. (Pubitemid 40523140)
5. Badiou S, Thiebaut R, Aurillac-Lavignolle V, Dabis F, Laporte F, Cristol JP, et al. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA). Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients. J Infect. 2008;57(1):47-54.
6. Calza L, Manfredi R, Pocaterra D, Chiodo F. Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy. J Infect. 2008;57(1):16-32.
7. Chiu B. Multiple infections in carotid atherosclerotic plaques. Am Heart J. 1999;138(5 Pt 2):S534-6. (Pubitemid 29523252)
8. Nieto FJ, Adam E, Sorlie P, Farzadegan H, Melnick JL, Comstock GW, et al. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation. 1996;94(5):922-7. (Pubitemid 26292841)
9. Siscovick DS, Schwartz SM, Corey L, Grayston JT, Ashley R, Wang SP, et al. Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: the cardiovascular health study. Circulation. 2000;102:2335-40.
10. Zhu J, Quyyumi AA, Norman JE, Costello R, Csako G, Epstein SE. The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. J Infect Dis. 2000;182(6):1583-7.
11. Auer J, Berent R, Weber T, Eber B. Influenza virus infection, infectious burden, and atherosclerosis. Stroke. 2002;33(2): 1454-5. (Pubitemid 34619935)
12. Lavallée P, Perchaud V, Gautier-Bertrand M, Grabli D, Amarenco P. Association between influenza vaccination and reduced risk of brain infarction. Stroke. 2002;33:513-8. (Pubitemid 34123398)
13. Auer J, Leitinger M, Berent R, Prammer W, Weber T, Lassnig E, et al. Influenza A and B IgG seropositivity and coronary atherosclerosis assessed by angiography. Heart Dis. 2002;4(6): 349-54. (Pubitemid 36014997)
14. Madjid M, Naghavi M, Litovsky S, Casscells SW. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation. 2003;108:2730-6. (Pubitemid 37498972)
15. Collins SD. Excess mortality from causes other than influenza and pneumonia during influenza epidemics. Public Health Rep. 1932;47:2159-80.
16. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons: a metaanalysis and review of the literature. Ann Intern Med. 1995;123(7): 518-27.
17. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of Myocardial Infarction. J Am Coll Cardiol. 2000;36(3):959-69.
18. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26:S5-20.
19. Whitworth JA, World Health Organization. International Society of Hypertension Writing Group. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983-92. (Pubitemid 38296854)
20. Lai S, Fishman EK, Lai H, Pannu H, Detrick B. Serum IL-6 levels are associated with significant coronary stenosis in cardiovascularly asymptomatic inner-city black adults in the US. Inflamm Res. 2009;58(1):15-21.
21. Leon ML, Zuckerman SH. Gamma interferon: a central mediator in atherosclerosis. Inflamm Res. 2005;54(10):395-411. (Pubitemid 41609377)
22. Jha HC, Divya A, Prasad J, Mittal A. Plasma circulatory markers in male and female patients with coronary artery disease. Heart Lung. 2010;39(4):296-303.
23. Van Lenten BJ, Wagner AC, Nayak DP, Hama S, Navab M, Fogelman AM. C-reactive protein is a mediator of cardiovascular disease. Eur Heart J. 2010;31(17):2087-91.
24. Rizvi AA. Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: emerging concepts. Am J Med Sci. 2009;338(4):310-8.
25. Van Lenten BJ, Wagner AC, Nayak DP, Hama S, Navab M, Fogelman AM. High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection. Circulation. 2001;103:2283-8. (Pubitemid 32433719)
26. Van Lenten BJ, Wagner AC, Anantharamaiah GM, Garber DW, Fishbein MC, Adhikary L, et al. Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide. Circulation. 2002;106:1127-32. (Pubitemid 34970855)
27. Bouwman JJ, Visseren FL, Bosch MC, Bouter KP, Diepersloot RJ. Procoagulant and inflammatory response of virus-infected monocytes. Eur J Clin Invest. 2002;32(10):759-66. (Pubitemid 35334972)
28. Visseren FL, Bouwman JJ, Bouter KP, Diepersloot RJ, de Groot PH, Erkelens DW. Procoagulant activity of endothelial cells after infection with respiratory viruses. Thromb Haemost. 2000;84: 319-24. (Pubitemid 30601481)
29. Naghavi M, Wyde P, Litovsky S, Madjid M, Akhtar A, Naguib S, et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation. 2003;107:762-8. (Pubitemid 36222607)
30. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003;348(14):1322-32. (Pubitemid 36384099)
31. Loppnow H, Werdan K, Buerke M. Invited review: vascular cells contribute to atherosclerosis by cytokine-and innate-immunityrelated inflammatory mechanisms. Innate Immun. 2008;14(2): 63-87.
32. Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res. 2008;79(3):360-76.
33. Nakou ES, Liberopoulos EN, Milionis HJ, Elisaf MS. The role of C-reactive protein in atherosclerotic cardiovascular disease: an overview. Curr Vasc Pharmacol. 2008;6(4):258-70.
34. Haidari M, Wyde PR, Litovsky S, Vela D, Ali M, Casscells SW, et al. Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice. Atherosclerosis. 2010;208(1):90-6.
35. Gurfinkel EP, de la Fuente RL, Mendiz O, Mautner B. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation. 2002;105: 2143-7. (Pubitemid 34517156)
36. Davis MM, Taubert K, Benin AL, Brown DW, Mensah GA, Baddour LM, American Heart Association, American College of Cardiology, et al. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation. 2006;114:1549-53. (Pubitemid 44527011)